Study S001984

The Effect of Semaglutide on Endothelial Function, Arterial Stiffness and Liver Indices in Patients Witn Type 2 Diabetes Mellitus and NAFLD

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06301191
Study type: OBSERVATIONAL
Status: UNKNOWN
Enrollment: 50
Start: 2022-03-01
Primary completion: 2023-03-01
Lead sponsor: Attikon Hospital
Conditions: Diabetes Type 2
Interventions: DRUG:Semaglutide, 1.0 mg/mL; DRUG:Dipeptidyl Peptidase 4 inhibitor
Results posted: FALSE

Registered primary outcomes

Comparison of arterial stiffness markers difference among treatment groups [12 months]
Comparison of endothelial glycocalyx thickness difference among treatment groups [12 months]
Comparison of liver stiffness difference among treatment groups [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.